-
WHO Identifies Resomelagon as One Of Six Dengue Drug Candidates with Evidence Supporting Further Clinical Development
LUND, SE / ACCESS Newswire / September 16, 2026 / SynAct Pharma AB (publ) (“SynAct”) (STO:SYNACT), a clinical-stage
Lifestyle Content
Technology
Entertainment
-
David vs. Silicon Valley: Shichida UK’s Cognitive 404 Game Outscores Apple and Reddit in Digital Design Review
-
LeCreasha Randall Turns Pain Toward Forgiveness in The Cords That Could Have Bound Me
-
Atua AI Strengthens Enterprise AI Coordination for Decentralized Digital Operations
-
Alexei Orlov Explains Why Global Brands Cannot Treat Every Market the Same
-
Pride Holdings Group Announces Launch of Pride Cell in Partnership with Perch Mobile
Health
-
Breeze Blends LLC Brings Gourmet All-Natural Seasonings to the World Food Championship for Third Consecutive Year
-
Meet BAGend: The Clever Australian Home Accessory Keeping Everyday Life Upright
-
Africa’s Next Business Opportunity May Begin in Texas: Global Investors Gather for 21st Annual Trade & Investment Conference
-
The Tomato Shack Expands Catering Appeal With Pizza In West Chester
-
The Tomato Shack Improves Pickup and Delivery Experience for Organic Pizza Restaurant Customers Through Chowly Integration
